Onset Acute or sub-acute Insidious. Fluctuating, usually resolves over Progressive
|
|
- Harold Logan
- 5 years ago
- Views:
Transcription
1 Guideline Name: Delirium Delirium is an acute confusional state characterised by a global disturbance in cerebral function affecting consciousness, attention, cognition and perception with a course that may fluctuate over a period of hours. It is a common cause of disturbed behaviour in medically ill patients and studies have shown that it is extremely common in palliative care patients. Studies have shown that 29-42% of patients have delirium on admission to a palliative care unit; 88% of patients in the last few days of life 1, 2. The symptoms of delirium are distressing for the patient, their relatives and care givers and expose the sufferer to the risk of further harm e.g. falls. Clinical Features Delirium may develop over hours to days and the symptoms and their severity can fluctuate over relatively short periods of time. The symptoms and signs include 3 : Cognitive impairment which can include problems with orientation, memory, visual spatial abilities, calculation, writing and reading. These features can be picked up by formal testing Altered levels of consciousness with changes in the level of awakeness (or arousal) on a spectrum of hyperalert (hyperactive delirium) to hypoalert (hypoactive delirium) and possible fluctuations between the two extremes over relatively short periods of time Disorders of the sleep-wake cycle Impaired attention Mood changes Hallucinations (false perceptions) and illusions (misperceptions) Delusions (abnormal thoughts) which are usually persecutory and can be the basis for aggressive behaviour Delirium is probably under-diagnosed in palliative care inpatients because the majority of cases (78%) fall into the hypoactive subtype where patients have slowed psychomotor function, lethargy, confusion, sedation, reduced awareness of their surroundings and impaired ability to sustain attention 2. The main differential diagnosis is that of dementia 4 and often delirium is superimposed on a pre-existing dementia. Table 1: Differences between delirium & dementia Delirium Dementia Onset Acute or sub-acute Insidious Course Fluctuating, usually resolves over Progressive days to weeks Conscious Level Often impaired, can fluctuate Clear until later stages rapidly Cognitive Defects Poor short term memory, poor attention span Poor short term memory, attention less affected until severe Hallucinations Common, especially visual Often absent Delusions Fleeting, non-systematised Often absent Psychomotor activity Increased, reduced or unpredictable Can be normal Page 1 of 10
2 Aetiology The pathophysiology of delirium is not fully understood. The reticular formation of the brainstem which regulates normal wakefulness and sleep is thought to be important. There are many neurotransmitters and receptors which are important for controlling wakefulness and consciousness and their modification (e.g. with drugs) can cause delirium. Acetylcholine is thought to be the most important which may explain why patients with dementia are at higher risk of developing delirium because of their already impaired cholinergic system 3. Delirium has a large number of possible causes. Common causes Medications e.g. Opioid toxicity, anti-cholinergics, hypnotics Drug withdrawal e.g. alcohol, illicit drugs Hypoxia Metabolic abnormalities e.g. renal or hepatic impairment, hypercalcaemia, dehydration Nutritional deficiency e.g. thiamine, folic acid, vitamin B12 Infections Cerebral metastases Assessment There are various screening tools available for the detection of delirium: Mini-Mental Test (see appendix 1) a 10 part test - screens memory and concentration - it is not specific for delirium and does not assess all components of cognition Mini-Mental State Examination (MMSE) a 30 part test sensitive to changes in cognition and also consciousness and attention it is not specific for delirium and will not differentiate delirium from dementia Confusion Assessment Method (see appendix 2) a diagnostic algorithm which is sensitive and specific but can only be applied by people with training 6 Nursing Delirium Screening Scale (see appendix 3) a new tool with reasonable sensitivity and specificity 7 Management Investigations should be aimed at eliminating common causes in order to improve symptom control especially considering that up to half of all cases of delirium in palliative care patients may be reversible 1, 5. The onset of delirium may not indicate imminent death but patients with irreversible delirium may have a shorter prognosis than those with a reversible cause. A shorter prognosis may also be related to increasing age, severity of cognitive impairment and evidence of organ failure 5. There are five main aspects to managing delirium: Ensure the patient s safety. A risk assessment will need to be performed. If necessary, the patient will require constant supervision. This can be provided by a relative or healthcare professional. If a patient is not responding to treatment or is a danger to themselves or others then the team leader caring for the patient should discuss the case further with the senior nurse and consultant to consider further options for care. Provide a safe and non-stimulating environment. A safe environment is one which limits the risk of harm to the patient i.e. removing objects which could be harmful, consider a mattress on the floor. The environment should also reduce the demands on the patient s impaired cognition i.e. adequate lighting, consistent staff, correction of sensory impairments, use of clocks and calendars and familiar objects. Page 2 of 10
3 Provide psychological support for the patient and family. Families need to be educated about delirium and the measures being used to combat it. They also need to be supported through a traumatic and difficult stage in their loved ones illness. Identify and treat the underlying cause. A full physical examination should be carried out looking for infection, dehydration, hypoxia and organ failure. Routine investigations should include FBC, U&Es, LFTs, TFTs, Ca 2+ and glucose Further investigations including CT or MRI imaging of the brain may also need to be considered. Drug charts should be scrutinised and possible offending medications reduced or stopped if appropriate. Opioids should be reduced or switched depending on results of renal function tests and the patient s symptoms. Prescribe drugs aimed at managing symptoms. Antipsychotic drugs: The side effect profile of each individual drug needs to be taken into account when prescribing anti-psychotics and weighed against the patients individual situation. It is especially important to note history of seizures, Parkinson s Disease, Lewy Body Dementia prostatic symptoms or hypotension. These drugs and their continued use needs to be reviewed on a daily basis, particularly if the underlying cause can be reviewed. 10 Main side effects of anti-psychotics Extra-pyramidal side effects (EPSEs): o Dystonic reactions o Pseudoparkinsonism o Akathisia o Tardive dyskinesia Reduced seizure threshold Postural hypotension Anticholinergic side effects (see appendix 4) Neuroleptic malignant syndrome Others hyperprolactinaemia, weight gain, cardiac side effects, sedation o Haloperidol 0.5-1mg PO/SC q 1 h p.r.n and at bedtime; if necessary titrate the dose gradually. Haloperidol should be kept at the lowest dose possible for the shortest amount of time. <60yrs doses could go up to the range 2.5-5mg but >60yrs doses should be kept lower in the range 0.5-1mg if possible. The maintenance dose is based on the initial cumulative dose needed to settle the patient. First line for management of delirium in palliative care as extensive experience in its use and ability to be given subcutaneously. Cochrane review has found efficacy of low dose haloperidol to be similar to newer atypical antipsychotics. At higher doses (>4.5mg/24 hours) there is increased risk EPSEs 9. Effect can be seen within hours to days. It is less sedating than chlorpromazine and has relatively few side effects. The major problem encountered is that of EPSEs, leading to Parkinson-like symptoms and a tendency to fall. It is metabolised by the liver and should be avoided in hepatic failure. Haloperidol is the drug of choice in hypoactive delirium. o Levomepromazine mg PO/SC stat, and at bedtime, may be used instead if a period of sedation is required in an agitated delirious patient. Excessive sedation and hypotension are limitations of this drug but it can be very useful in terminal agitation (not recommended by NICE) o Olanzapine <60yrs 5mg and >60yrs 2.5mg PO/SC stat, p.r.n. and at bedtime. If necessary, increase to 5-10mg at bedtime. Found to be as effective as low dose antipsychotics 9 and may be worth considering if high dose haloperidol required but causing side effects. Can be sedative and cause postural hypotension. Depending on response daily dose is around mg. Page 3 of 10
4 Benzodiazepines Not generally recommended for the management of delirium unless it is related to alcohol withdrawal as benzodiazepines can worsen the symptoms of delirium. If delirium is felt to be irreversible and is causing symptoms of agitation and restlessness that cannot be managed in any other way then it may be appropriate to use benzodiazepines for symptom control. This may be in addition to antipsychotic medication. o o o o Diazepam 2-5mg orally up to tds Lorazepam 0.5-2mg sublingually PRN (up to 4 hourly) Midazolam via continuous subcutaneous infusion starting at 5-10mg/24hrs and titrating to response Midazolam mg subcutaneously PRN Regular clinical review and follow up. This needs to be done on a daily basis and short term use of less than one week for medications should be considered. Advice regarding the newer antipsychotics and new dementia drugs can be sought from the local psychiatric team. 24hrs Single Point of Access for support for mental health problems Terminal Agitation Symptoms of agitation and restlessness at the end of life may be due to a delirium that is irreversible or it may be inappropriate to investigate them. Under these circumstances palliative sedation therapy may be required. Sedatives should be used proportionately and titrated to response. Midazolam - typical starting dose 10mg/24hrs (range up to 100mg) Levomepromazine - typical starting dose 25mg/24hrs (range up to 100mg) Phenobarbitone - typical starting dose 200mg/24hrs (range up to 600mg) Palliative sedation therapy (PST) is the use of specific sedative medications to relieve intolerable suffering from refractory symptoms by a reduction in patient consciousness. The symptoms most commonly requiring PST are delirium, dyspnoea, pain and nausea or vomiting. The aim of PST is to relieve such symptoms by means of appropriate sedative drugs carefully titrated to the cessation of symptoms. Usually, symptom relief can be achieved with levels of sedation that do not prevent the patient from being able to communicate. It is unusual for a patient to require deep sedation from the initiation of PST. PST can be continuous or intermittent. Related guidelines and policies Guidelines for the Use of Sedation Guidelines for the Management of Psychosis References 1. Lawlor PG et al. Occurrence, causes and outcome of delirium in patients with advanced cancer. Arch Intern Med 2000;160: Spiller JA. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliative Medicine 2006; 20: Caraceni A, Simonetti F. Palliating delirium in patients with cancer (review). Lancet oncology 2009; 10: Brown TM and Boyle MF. ABC of psychological medicine: Delirium BMJ 2002: 325; Leonard M et al. Reversibility of delirium in terminally ill patients and predictors of mortality. Palliative Medicine 2008; 22: Page 4 of 10
5 6. Wei L, Fearing M, Sternberg E, Inouye SK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc 2008; 56: Gaudreau J, Gagnon P, Harel F, Tremblay A, Roy M, Fast, systematic and continuous delirium assessment in hospitalised patients: the Nursing Delirium Screening Scale. J Pain Symptom Manage 2005; 29: Gagnon PR. Treatment of delirium in supportive and palliative care. Current Opinion in Supportive and Palliative Care 2008; 2: Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev NICE; NCGC Delirium, diagnosis, prevention and treatment; Clinical Guideline 103, July 2010; Date Originated: December 2006 Original Author: Date of last review: November 2011 Date of this review: November 2014 Reviewed By: Dr Bruno Capone Next Review Due: October 2018 Issuing Authority: Dr Helen McGee, Consultant Page 5 of 10
6 Appendix 1 Mini-Mental test Score one point for each question answered correctly and give score out of 10. Question - Patient s age - Time (to nearest hour) - Address given for recall at end of test (42 West Street) - Name of hospital (or town if at home) - Current Year - Patient s date of birth - Current month - Years of the first world war - Name of the monarch - Count backwards from 20 to 1 (no errors allowed but may correct self) Page 6 of 10
7 Appendix 2 Confusion Assessment Method (CAM) Shortened Version Worksheet If all items in Box 1 are checked and at least one item in Box 2 is checked a diagnosis of delirium is suggested. Page 7 of 10
8 Appendix 3 The Nursing Delirium Screening Scale (Nu-DESC) Features and descriptions Symptoms Rating (0-2) Symptom Time Period Midnight 8 AM 8 AM 4 PM 4 PM Midnight I. Disorientation Verbal or behavioural manifestation of not being oriented to time or place or misperceiving persons in the environment. II. Inappropriate behaviour Behaviour inappropriate to place and/or time for the person; e.g. pulling at tubes or dressings, attempting to get out of bed when that is contraindicated, and the like. III. Inappropriate communication Communication inappropriate to place and/or for the person; e.g. incoherence, non-communicativeness, nonsensical or unintelligible speech. IV. Illusions/Hallucinations Seeing or hearing things that are not there; distortions of visual objects. V. Psychomotor retardation Delayed responsiveness, few or no spontaneous actions/words; e.g. when the patient is prodded, reaction is deferred and/or the patient is unrousable. Total Score Symptoms are rated from 0 to 2 based on the presence and intensity of each symptom and individual ratings are added to obtain a total score per shift. The patient is considered positive on screening if presenting a score of 2 or more. Page 8 of 10
9 Generic Name Alverine Alprazolam Atenolol Bupropion Captopril Chlorthalidone Cimetidine Clorazepate Codeine Colchicine Diazepam Digoxin Dipyridamole Disopyramide Fentanyl Furosemide Fluvoxamine Haloperidol Hydralazine Hydrocortisone Isosorbide Loperamide Metoprolol Morphine Nifedipine Prednisone Quinidine Ranitidine Risperidone Theophylline Trazodone Triamterene Warfarin Complete References: Drugs with Possible Anticholinergic Effects Brand Name Spasmonal Xanax Tenormin Wellbutrin, Zyban Capoten Diuril, Hygroton Tagamet Tranxene Contin Colcrys Valium Lanoxin Persantine Norpace Duragesic, Actiq Lasix Luvox Haldol Apresoline Cortef, Cortaid Isordil, Ismo Imodium, others Lopressor, Toprol MS Contin, Avinza, Roxanol Procardia, Adalat, Nifedical Deltasone, Sterapred Quinaglute Zantac Risperdal Theodur, Uniphyl Desyrel Dyrenium Coumadin 1. Boustari MA, Campbell NL. Munger S, Maidment I, Fox C=GC,. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008: 4(3): Campbell N, Boustari M, Limbil T, Ott C, et al. The cognitive impact of anticholinergics: a clinical review. Clinical Intervention in Aging. 2009:4(1): /27/12 Do not reproduce without permission contact acb@agingbraincare.org Appendix 4 ANTICHOLINERGIC COGNITIVE BURDEN SCALE Developed by the Aging Brain Program of the IU Center for Aging Research Generic Name Amantadine Amitriptyline Amoxapine Atropine Benztropine Brompheniramine Carbamazepine Carbinoxamine Chlorpheniramine Chlorpromazine Clemastine Clomipramine Clozapine Cyclobenzaprine Darifenacin Desipramine Dicyclomine Dimenhydrinate Diphenhydramine Doxepin Flavoxate Hydroxyzine Hyoscyamine Imipramine Meclizine Meperidine Methocarbamol Nortriptyline Olanzapine Orphenadrine Oxcarbazepine Oxybutynin Paroxetine Perphenazine Promethazine Propantheline Quetiapine Scopolamine Thioridazine Tolterodine Trifluoperazine Trihexyphenidyl Trimipramine Drugs with Definite Anticholinergic Effects Brand Name Symmetrel Elavil Asendin Sal-Tropine Cogentin Dimetapp, Lodrane Tegretol Histex, Carbihist Chlor-Trimeton, Chlorphen Thorazine Tavist Anafranil Clozaril Flexeril Enablex Norpramin Bentyl Dramamine, others Benadryl, others Sinequan, Zonalon Urispas Atarax, Vistaril Anaspaz, Cystospaz, Levsin Tofranil Antivert, Bonine Demerol Robaxin Pamelor Zyprexa Norflex Trileptal Ditropan Paxil Trilafon Phenergan Pro-Banthine Seroquel Scopace, Transderm Scop Mellaril Page 9 of 10 Detrol Stelazine Artane Surmontil
10 The following represents a list of alternative medications developed by an interdisciplinary group of specialists within the Aging Brain Program at Indiana University. These suggestions do not supersede clinical judgment, and are intended to assist clinicians in practicing in acute health care settings who provide care for patients with cognitive impairment such as dementia, mild cognitive impairment or delirium. Recommended alternatives to medications with Definite Anticholinergic Properties Class ACB Drugs Alternatives Brompheniramine Carbinoxamine Allergies or itching: Chlorpheniramine Loratadine or Cetirizine orally First-Generation Clemastine Antihistamines Diphenhydramine Insomnia: Dimenhydrinate Trazadone orally Hydroxyzine Recommended alternatives to medications with Definite Anticholinergic Properties Class ACB Drugs Alternatives Bladder Antispasmodics Darifenacin Flavoxate Oxybutynin Propantheline Tolterodine Hold during acute care stay consider scheduling toileting Antidepressants Amitriptyline Amoxapine Clomipramine Desipramine Doxepin Imipramine Nortriptyline Paroxetine Trimipramine (Clinical judgment to consider if taper warranted) Depression: Sertraline or Citalopram orally Neuropathic pain: Gabapentin orally Insomnia: Trazadone orally GI Antispasmodics Antiemetics Atropine Dicyclomine Hyoscyamine Propantheline Hydroxyzine Meclizine Promethazine Scopolamine Reflux disorders: Esomeprazole orally Painful abdominal cramps: Morphine orally or IV Consider ondansetron IV or PO, or Metoclopramide PO Antipsychotics Chlorpromazine Clozapine Olanzapine Perphenazine Quetiapine Thioridazine Trifluoperazine (Recommendation does not apply to chronic use for psychiatric diagnosis) Acute care environment: Haloperidol orally or IM for 72 hours only Skeletal Muscle Relaxants Cyclobenzaprine Methocarbamol Acetaminophen or oxycodone/ acetaminophen Analgesics Meperidine Morphine sulfate orally or IV Central Anticholinergics Amantadine Benztropine Trihexyphenidyl Orphenadrine Movement disorders: Dopamine agonists or levodopa Antiepileptics Carbamazepine Oxcarbazepine Seizures: Consult neurology for alternative Neuropathic pain: Gabapentin or levetiracetam orally Mood disorders: Consult psychiatry for alternative 6/27/12 Do not reproduce without permission contact acb@agingbraincare.org For more information or permission to duplicate, please contact: Noll Campbell, PharmD or Malaz A. Boustani, MD, MPH Regenstrief Institute, Inc./IU Center for Aging Research 410 West 10 th Street, Suite 2000 Indianapolis, IN Phone: (317) Fax: (317) acb@agingbraincare.org Page 10 of 10
3D s. Delerium Dementia Depression
3D s Delerium Dementia Depression Greg Thomson M.D. Family Physician Medical Program Lead Rehabilitation and Geriatrics Halton Healthcare August 2017 Collaboration with Dr. T. Bibic Copyright 2017 by Sea
More informationSupplementary Online Content
Supplementary Online Content Risacher SL, McDonald BC, Tallman EF, et al; Alzheimer s Disease Neuroimaging Initiative. Association between anticholinergic medication use and cognition, brain metabolism,
More informationManagement of Delirium in Hospice Patients
Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying
More informationPharmacy Drug Class Review
Pharmacy Drug Class Review April 15, 2014 Authored By: Gina DeRue PharmD, CDE, BCACP Disclaimer: Specific agents may have variations Edited By: Richard J. Kraft, Pharm.D.BCPS ANTICHOLINERGIC BURDEN A focus
More informationDelirium. Assessment and Management
Delirium Assessment and Management Goals and Objectives Participants will: 1. be able to recognize and diagnose the syndrome of delirium. 2. understand the causes of delirium. 3. become knowledgeable about
More informationLearning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016
Terminal Restlessness Dr. Christopher Churchill St. Cloud VA Health Care System EC&R Service Line Director & Medical Director Hospice & Palliative Care March 31, 2016 Learning Objectives Different Terminology
More informationHave You Ever Wondered
Have You Ever Wondered A few facts about medication use and related falls The Number of Medications You Take & The Connection to Falls CONCERN: As you increase the number of medications that you take,
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationDelirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care
Delirium A Plan to Reduce Use of Restraints David Wensel DO, FAAHPM Medical Director Midland Care Objectives Define delirium Describe pathophysiology of delirium Understand most common etiologies Define
More informationDelirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen
Delirium Dr. Lesley Wiesenfeld Deputy Psychiatrist in Chief, Mount Sinai Hospital Dr. Carole Cohen Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre Case Study Mrs B
More informationSupplementary Online Content
Supplementary Online Content Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. Published online January
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationMay 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator:
May 22, 2013 DAL: DAL 13-11 SUBJECT: Hot Weather Advisory Dear Administrator/Operator: The New York State Department of Health would like to remind you of our expectations regarding the protection of Adult
More informationPennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016
Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Drugs in Older Adults: Beers Criteria Heather Sakely,
More informationDelirium. Approach. Symptom Update Masterclass:
Symptom Update Masterclass: Delirium Jason Boland Senior Clinical Lecturer and Honorary Consultant in Palliative Medicine Wolfson Centre for Palliative Care Research Hull York Medical School University
More informationMedicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More informationHow did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh
Polypharmacy, Adverse Effects, and the Importance of Tapering Medications for People with Intellectual and Developmental Disabilities Garrett McCann, RPh How did we get here? 1876 Methylene Blue Insecticide
More informationAntipsychotic Medication
Antipsychotic Medication Mary Knutson, RN 3-7-12 Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Clinical Uses of Antipsychotics Short-term: in severe depression and
More informationDelirium Assessment. February 24, Susan Schumacher, MS, APRN-BC
Delirium Assessment February 24, 2016 Susan Schumacher, MS, APRN-BC Objectives Define delirium Differentiate delirium from dementia Identify predisposing and precipitating factors leading to delirium.
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Pretest 1. Appropriate target symptoms for emergency room medication treatment
More information2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources
Drugs and Dementia in the Hospice Patient Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources 1 Drug Therapy: Targeted at Symptoms Cognitive: Impaired abstract thinking Impaired
More informationDo benzos, opioids, or strong anticholinergics cause delirium? Lisa Burry
Do benzos, opioids, or strong anticholinergics cause delirium? Lisa Burry Delirium in the ICU Occurs in up to 85% of MICU/SICU MV patients 20-50% of lower severity ICU patients develop delirium Hypoactive
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationDelirium. Quick reference guide. Issue date: July Diagnosis, prevention and management
Issue date: July 2010 Delirium Diagnosis, prevention and management Developed by the National Clinical Guideline Centre for Acute and Chronic Conditions About this booklet This is a quick reference guide
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationDelirium in Cancer: Psychopharmacologic Management
Delirium in Cancer: Psychopharmacologic Management William Breitbart, MD Professor and Chief, Psychiatry Service Memorial Sloan-Kettering Cancer Center New York, New York Delirium in Patients with Cancer
More informationDebra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017
Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationDelirium in the Elderly
Delirium in the Elderly ELITE 2015 Mamata Yanamadala M.B.B.S, MS Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationUse of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
More informationSymptom Management Pocket Guides: DELIRIUM
Symptom Management Pocket Guides: DELIRIUM August 2010 DELIRIUM Page Considerations. 1 Assessment 2 Diagnosis. 3 Non-Pharmacological treatment 3 Pharmacological treatment. 5 Mild Delirium... 6 Moderate
More informationDelirium in the Elderly
Delirium in the Elderly ELITE 2017 Liza Genao, MD Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity Very much under-recognized
More informationMedicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay
Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay (Revised edition November 2015) The Medicine Related Falls Risk Assessment
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationDelirium. Delirium. Delirium Etiology and Pathophysiology. Fall 2018
Three most common cognitive problems in adults 1. (acute confusion) 2. Dementia 3. Depression These problems often occur together Can you think of common stimuli for each? 1 1 State of temporary but acute
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Pretest 1. Which of the following conditions is LEAST likely to benefit from emergency
More informationg Prevention, Diagnosis, and Management in Palliative Care
8/3/2012 Improving p g Prevention, Diagnosis, g and Management in Palliative Care MN Rural Palliative Care Networking Group Quarterly Education Session June 27,2012 Sandra W. Gordon-Kolb, MD, MMM, CPE
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationThe Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State
The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State RAI/MDS Coordinator Objectives Upon completion of this training,
More informationMaking Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics. Session Objectives. January 2018
Making Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics Bridget McCrate Protus, PharmD, MLIS, BCGP, CDP Director of Drug Information Optum Hospice Pharmacy Services Session Objectives
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationGUIDELINES FOR THE MANAGEMENT OF DELIRIUM IN ADVANCED CANCER
GUIDELINES FOR THE MANAGEMENT OF DELIRIUM IN ADVANCED CANCER 14.1 GENERAL PRINCIPLES Delirium can be defined as: A transient organic brain syndrome characterised by the acute onset of disordered arousal
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationInterprofessional Webinar Series
Interprofessional Webinar Series Assessment and Management of Delirium Pauline Lesage, MD, LLM Physician Educator MJHS Institute for Innovation in Palliative Care Disclosure Slide Pauline Lesage, MD, LLM,
More informationMedications: The Dark Side
Medications: The Dark Side Robert P. Smith, MD Potential Mechanisms of Drug Effects Metabolic effects Alterations of Immunologic factors in CNS Interference with synaptic transmission Excess dopaminergic
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationPalliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers
Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers This formulary is current as of February 11, 2010. Important Notes: Pharmacists must submit a claim on PharmaNet at the time
More informationTreatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers
Treatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers By Kelsey F. Lee, PharmD candidate 2011 Preceptor: Demetra Antimisiaris, PharmD University of Louisvlle Dept. Family Medicine
More informationMO Medicaid Foster Care Drugs FY10-FY14
MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri
More informationObjectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition
Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change
More informationPHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationBEHAVIORAL PROBLEMS IN DEMENTIA
BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and
More informationPOST STROKE DELIRIUM. Dr Janet Ballantyne
POST STROKE DELIRIUM Dr Janet Ballantyne Delirium de: away from/off lira: ridge between ploughed farrows/tracks off the tracks Acute confusional state Acute brain syndrome Acute brain failure Metabolic
More informationDementia Pharmacotherapy
Dementia Pharmacotherapy 1 early therapeutic interventions can maximize pharmacologic efficacy with these agents 2 Selecting a Medication Not enough evidence to recommend one agent over another based on
More informationDrugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD
Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be
More informationWorkshop 4: Preventing Falls through Medication Vigilance
Workshop 4: Preventing Falls through Medication Vigilance Nancy L. Losben, R.Ph., CCP, FASCP, CG Chief Quality Officer Omnicare, Inc. & Diane C. Vaughn, RN, C-DONA/LTC, LNHA VP, Clinical Services Benedictine
More information1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER
1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.
More informationFall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)
Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who
More informationALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
More informationPAIN MANAGEMENT Person established taking oral morphine or opioid naive.
PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationNatural Medicines Food-Drug Interactions and Other Interesting Stuff
Natural Medicines Food-Drug Interactions and Other Interesting Stuff Homeopathy Like treats Like More dilute = More potent Potentization serial dilutions Forrest Batz, PharmD Assistant Professor of Pharmacy
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationDELIRIUM. Approach and Management
DELIRIUM Approach and Management By Dr. K.S. Jacob, Professor of Psychiatry and Dr. Anju Kuruvilla, Professor of Psychiatry, Christian Medical College, Vellore. Based on a chapter in the book Psychiatric
More informationSt Francis Hospice. How common is it? How is it prevented? 10/07/2017. What is delirium? DSM IV criteria. Delirium vs Dementia.
What is delirium? DSM IV criteria St Francis Hospice Dr Hilary Kinsler Disturbance of consciousness reduced clarity of awareness of the environment Change in cognition memory deficit, disorientation, language
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More informationCognitive disorders. Dr S. Mashaphu Department of Psychiatry
Cognitive disorders Dr S. Mashaphu Department of Psychiatry Delirium Syndrome characterised by: Disturbance of consciousness Impaired attention Change in cognition Develops over hours-days Fluctuates during
More informationSiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]
SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA [compatible with NICE guidance] Medicines Management Committee August 2002 For review August 2003 Rationale The SiGMA algorithm
More informationPalliative Care and Delirium. Ambereen K. Mehta, MD MPH Assistant Professor Division of General Medicine, Geriatrics, and Palliative Care
Palliative Care and Delirium Ambereen K. Mehta, MD MPH Assistant Professor Division of General Medicine, Geriatrics, and Palliative Care Disclosures I have no personal or professional financial relationships
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationSymptom Management Guidelines for End of Life Care
Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can
More informationHigh-risk medications in older adults drug alternative(s)
Antianxiety Analgesics Antihypertensive High-risk medications in older adults drug alternative(s) Guanabenz Guanfacine Methyldopa Reserpine (greater than 0.1 mg per day) High risk of adverse central nervous
More information#55 PRESCRIBING AND MONITORING PSYCHI RIC MEDICATIONS
- '_ ADMINISTRA TIVE/FISCAUCLINICAL/PHF POLICY AND PROCEDURES COUNTY OF SANTA BARBARA ALCOHOL, DRUG AND MENTAL HEAL TH SERVICES Section - QUALITY ASSURANCE Effective: 12/1/09 Policy- Director's Approval
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More informationAnthony J. Caprio, MD, CMD, AGSF 1
Objectives 1) Discuss the dangers of polypharmacy 2) Review potentially inappropriate medications for older adults Doc, I think I am taking too many medications! 3) Develop strategies for prioritizing
More informationGUIDELINES FOR DIAGNOSIS, PREVENTION AND TREATMENT OF DELIRIUM IN THE INPATIENT SETTING
GUIDELINES FOR DIAGNOSIS, PREVENTION AND TREATMENT OF DELIRIUM IN THE INPATIENT SETTING Policy Details NHFT document reference MMG033 Version Final Date Ratified May 2016 Ratified by Medicines Management
More informationBehavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.
Behavioral Issues in Dementia March 27, 2014 Dylan Wint, M.D. OVERVIEW Key points Depression Definitions and detection Treatment Psychosis Definitions and detection Treatment Agitation SOME KEY POINTS
More informationDealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
More informationDelirium in Hospital Care
Delirium in Hospital Care Dr John Puxty 1 Learning Objectives By the end of the workshop participants will be able to: Appreciate the main diagnostic criteria for delirium. Describe common risk factors,
More informationQuality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety
Quality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:
More informationAAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationChapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses
Chapter 17 Psychoses Drugs for Psychoses Delusions Hallucinations Illusions Paranoia Upper Saddle River, New Jersey 07458 All rights reserved. Classifications of Psychoses Acute episode Chronic episode
More informationPolicy Evaluation: Low Dose Quetiapine Safety Edit
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University 500 Summer Street NE, E35, Salem, Oregon 97301 1079 Phone 503 947 5220 Fax 503
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationPotentially Inappropriate Medication Use in Older Adults 2015 Latest Research
Home Resources Potentially Inappropriate Medication Use in Older Adults 2015 Resources Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Drugs and Categories of Drugs What these
More informationBACKGROUND Measuring renal function :
A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal
More informationDelirium Screening Tools: Just- In- Time Education and Evaluation Using the EMR
Delirium Screening Tools: Just- In- Time Education and Evaluation Using the EMR Implementation of an EMR based protocol for detection of delirium in elderly Medical and palliative care patients Parul Goyal,
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationPsychotropic Strategies Handout Package
Psychotropic Strategies Handout Package Psychotropic Strategies Learning Objectives Utilize all clinical information available Assess the patient s overall condition this is essential Basic Principles
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationDelirium. Dr. John Puxty
Delirium Dr. John Puxty Learning Objectives By the end of the workshop participants will be able to: Appreciate the main diagnostic criteria for delirium. Describe common risk factors, causes and main
More information